Neuropace Finds $74M For Epilepsy Treatment
Mountain View-based NeuroPace, a developer of neurostimulation systems to treat epilepsy, has raised $74M in a funding round. The funding was led by KCK Group and OrbiMed Advisors. The company is developing a brain-responsive neurostimulation system designed to prevent epileptic seizures. The company said the funding goes towards commercialization efforts for its FDA-approved device. NeuroSpace's CEO is Frank Fischer.
posted on Tuesday, October 24, 2017 (Link to more information)
Related companies:
NeuroPace Inc
Related stories:
> Oyster Point Pharma Finds $22M For Dry Eye Treatment
> Portaero Quietly Gets Funding For COPD Treatment
> Avidia Acquired by Amgen
> Intarcia Therapeutics Finds $50M
> EBR Systems Raises $50M For Wireless Heart Failure Treatment System
silicontap.com Home